来自SARS-CoV-2阳性供体的心脏移植。墨西哥首例病例

IF 0.3 Q4 SURGERY
Guillermo Careaga-Reyna , Hugo Jesús Zetina-Tun , Leticia Arizbeth Hernández-Castro , Hugo Arturo Álvarez-Alvarado , Aidé Saraí de la Cruz-Domínguez , Luis Manuel Álvarez-Sáncheza
{"title":"来自SARS-CoV-2阳性供体的心脏移植。墨西哥首例病例","authors":"Guillermo Careaga-Reyna ,&nbsp;Hugo Jesús Zetina-Tun ,&nbsp;Leticia Arizbeth Hernández-Castro ,&nbsp;Hugo Arturo Álvarez-Alvarado ,&nbsp;Aidé Saraí de la Cruz-Domínguez ,&nbsp;Luis Manuel Álvarez-Sáncheza","doi":"10.1016/j.circv.2023.01.001","DOIUrl":null,"url":null,"abstract":"<div><p>The COVID-19 pandemic affected transplant programs by decreasing the number of procedures performed. Although they have already restarted, the lack of donors is a limitation, given the possibility of transmission of the virus. Currently, transplants have been performed under special conditions from SARS-CoV-2 positive donors. We present the case of a 58-year-old male patient with refractory heart failure secondary to residual postinfarction interventricular septal defect who received heart from a 16-year-old asymptomatic, SARS-CoV-2-positive donor. The procedure was performed without complications, with favorable postoperative evolution, discharged 15 days posttransplant. Currently asymptomatic and with no evidence of SARS-CoV-2 infection. This is the first case in Mexico carried out under these conditions.</p></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"31 1","pages":"Pages 21-24"},"PeriodicalIF":0.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1134009623000013/pdfft?md5=6a9bbb04604dac753e203c7e01f42a6e&pid=1-s2.0-S1134009623000013-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Trasplante de corazón a partir de donante positivo a SARS-CoV-2. Primer caso en México\",\"authors\":\"Guillermo Careaga-Reyna ,&nbsp;Hugo Jesús Zetina-Tun ,&nbsp;Leticia Arizbeth Hernández-Castro ,&nbsp;Hugo Arturo Álvarez-Alvarado ,&nbsp;Aidé Saraí de la Cruz-Domínguez ,&nbsp;Luis Manuel Álvarez-Sáncheza\",\"doi\":\"10.1016/j.circv.2023.01.001\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The COVID-19 pandemic affected transplant programs by decreasing the number of procedures performed. Although they have already restarted, the lack of donors is a limitation, given the possibility of transmission of the virus. Currently, transplants have been performed under special conditions from SARS-CoV-2 positive donors. We present the case of a 58-year-old male patient with refractory heart failure secondary to residual postinfarction interventricular septal defect who received heart from a 16-year-old asymptomatic, SARS-CoV-2-positive donor. The procedure was performed without complications, with favorable postoperative evolution, discharged 15 days posttransplant. Currently asymptomatic and with no evidence of SARS-CoV-2 infection. This is the first case in Mexico carried out under these conditions.</p></div>\",\"PeriodicalId\":42671,\"journal\":{\"name\":\"Cirugia Cardiovascular\",\"volume\":\"31 1\",\"pages\":\"Pages 21-24\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S1134009623000013/pdfft?md5=6a9bbb04604dac753e203c7e01f42a6e&pid=1-s2.0-S1134009623000013-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cirugia Cardiovascular\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1134009623000013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"SURGERY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cirugia Cardiovascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134009623000013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

摘要

COVID-19 大流行影响了移植计划,减少了移植手术的数量。尽管这些计划已经重新启动,但由于病毒传播的可能性,供体的缺乏仍是一个限制因素。目前,已在特殊条件下对 SARS-CoV-2 阳性供体进行了移植。我们介绍了一例因梗死后室间隔缺损残留而继发难治性心力衰竭的 58 岁男性患者,他接受了来自 16 岁无症状、SARS-CoV-2 阳性供体的心脏。手术过程无并发症,术后恢复良好,移植后 15 天出院。目前无症状,无 SARS-CoV-2 感染迹象。这是墨西哥首例在这种情况下进行的移植手术。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Trasplante de corazón a partir de donante positivo a SARS-CoV-2. Primer caso en México

The COVID-19 pandemic affected transplant programs by decreasing the number of procedures performed. Although they have already restarted, the lack of donors is a limitation, given the possibility of transmission of the virus. Currently, transplants have been performed under special conditions from SARS-CoV-2 positive donors. We present the case of a 58-year-old male patient with refractory heart failure secondary to residual postinfarction interventricular septal defect who received heart from a 16-year-old asymptomatic, SARS-CoV-2-positive donor. The procedure was performed without complications, with favorable postoperative evolution, discharged 15 days posttransplant. Currently asymptomatic and with no evidence of SARS-CoV-2 infection. This is the first case in Mexico carried out under these conditions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.50
自引率
66.70%
发文量
109
审稿时长
69 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信